Literature DB >> 24597439

Levels of Recovery Scale (LORS): psychometric properties of a new instrument to assess psychotic symptoms and patient awareness.

Donald P Corriveau1, Sharon Sousa2.   

Abstract

This study developed norms and examined psychometric properties of the LORS, an instrument designed to assess symptoms of psychotic illness and patients' awareness of their symptoms. Participants were 90 patients with psychotic illnesses. The LORS was completed by trained clinicians (LORS-Clinician Scale) and patients themselves (LORS-Patient). To assess patients' self-awareness of psychotic symptoms, a derived scale (LORS-Discrepancy) was computed by subtracting the LORS-Patient Scale score from the LORS-Clinician Scale score. All scales showed good test-retest reliability. The LORS-Clinician Scale showed good concurrent validity. LORS-Patient Scale scores were significantly lower than LORS-Clinician Scale scores, suggesting that patients underestimated their psychotic symptoms. Patients with low awareness of their psychotic symptoms showed less appropriate functioning, more problems in complying with their medication regimens, and increased positive and negative symptoms of schizophrenia. Implications for developing treatments using the LORS-Discrepancy Scale were discussed.

Entities:  

Mesh:

Year:  2013        PMID: 24597439     DOI: 10.2466/03.07.02.PR0.113x20z0

Source DB:  PubMed          Journal:  Psychol Rep        ISSN: 0033-2941


  2 in total

Review 1.  A systematic search and critical review of studies evaluating psychometric properties of patient-reported outcome measures for schizophrenia.

Authors:  Benjamin Buck; Emily C Gagen; Tate F Halverson; Arundati Nagendra; Kelsey A Ludwig; John C Fortney
Journal:  J Psychiatr Res       Date:  2021-12-27       Impact factor: 4.791

2.  Self versus informant reports on the specific levels of functioning scale: Relationships to depression and cognition in schizophrenia and schizoaffective disorder.

Authors:  Julia Ermel; Cameron S Carter; James M Gold; Angus W MacDonald; J Daniel Ragland; Steven M Silverstein; Milton E Strauss; Deanna M Barch
Journal:  Schizophr Res Cogn       Date:  2017-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.